SynthesisBMC neurology2025
Immunonutrition for modifying inflammatory markers and improving clinical outcomes following traumatic brain injury: a systematic review and meta-analysis.
Synthesis in BMC neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTraumatic brain injury (TBI) induces a severe hypermetabolic state with elevated energy expenditure and progressive systemic inflammation. Nutritional optimization in this setting is challenging, particularly in severe TBI (Glasgow Coma Scale [GCS] = 3–8). Its clinical role in these hospitalized TBI patients remains unclear. This systematic review and meta-analysis aimed to evaluate the impact of immunonutrition on neuroinflammation and neurosurgical outcomes in TBI patients, with a focus on omega-3 fatty acids, arginine, and glutamine.
methodsFollowing the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidelines, we systematically reviewed the available evidence from PubMed, Scopus, and Web of Science. The inclusion criteria focused on severely hospitalized TBI patients with a GCS score of 3 to 8 who were receiving immunonutrition components. The quality and certainty of the evidence were assessed using the Cochrane Risk of Bias tool and the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach, respectively.
resultsA total of 12 studies were eligible and included in our comprehensive full-text review. However, only 5 articles were included in the meta-analysis. Systematic review findings indicated that immunonutrition was associated with reductions in inflammatory markers, decreased rates of nosocomial infections, and improvements in CO₂ reactivity, blood–brain barrier integrity, and cerebral edema. The meta-analysis results showed non-significant trends toward a lower mortality rate (p = 0.06), shorter hospital length of stay (LOS) (p = 0.09), and reduced ICU LOS (p = 0.12). Considerable heterogeneity was observed across some outcomes; however, due to the limited number of studies, formal meta-regression was not statistically justified. Instead, leave-one-out sensitivity analyses were performed to confirm the stability and robustness of the pooled estimates, alongside efforts to reduce heterogeneity.
conclusionsDespite heterogeneity and a limited number of studies, consistent trends support the beneficial role of immunonutrition in severe TBI. These findings highlight the physiological plausibility and clinical safety of such interventions, warranting larger, standardized trials to confirm these effects.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.